Home / Technology / Withings Partners With Abbott for Glucose Insights
Withings Partners With Abbott for Glucose Insights
6 Jan
Summary
- Abbott Lingo glucose data will be viewable in the Withings app by Q1 2026.
- Nondiabetics can purchase Abbott Lingo CGMs directly from Withings for $89.
- This partnership aligns with Withings' focus on metabolic and cardiovascular health.
Withings has announced a significant new partnership with Abbott, set to enhance metabolic health monitoring for its users. Beginning in the first quarter of 2026, individuals using Abbott's Lingo continuous glucose monitor (CGM) will have their glucose data seamlessly integrated into the Withings health application. This integration aims to provide a more comprehensive view of users' metabolic well-being.
The collaboration extends to product availability, with Withings’ U.S. website set to offer Abbott’s over-the-counter Lingo CGMs. These devices, designed for individuals without diabetes, will be available for $89 for a pack of two sensors. This move positions Withings as a direct vendor for essential metabolic health tracking tools.
This announcement aligns perfectly with Withings' recent introduction of a new smart scale, conceptualized as a "longevity station." Metabolic health, particularly glucose levels, alongside cardiovascular health, forms the core focus of this new device. The partnership with Abbott echoes similar industry trends, such as the collaboration between Oura and Dexcom.



